Medexus Pharmaceuticals Overview
- Year Founded
-
2003
- Status
-
Public
- Employees
-
82
- Stock Symbol
-
MDP
- Investments
-
4
- Share Price
-
$1.65
- (As of Tuesday Closing)
Medexus Pharmaceuticals General Information
Description
Medexus Pharmaceuticals Inc is a specialty pharmaceutical company with a powerful North American commercial platform and a growing portfolio of inventive and rare disease treatment solutions. The company's focus is on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology.
Contact Information
Website
www.medexus.comCorporate Office
- 10 King Street East
- Suite 600
- Toronto, Ontario M5C 1C3
- Canada
Corporate Office
- 10 King Street East
- Suite 600
- Toronto, Ontario M5C 1C3
- Canada
Medexus Pharmaceuticals Stock Performance
(As of Tuesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$1.65 | $1.59 | $1.06 - $2.37 | $40.4M | 24.5M | 21.6K | $0.05 |
Medexus Pharmaceuticals Financials Summary
In Thousands, USD |
TTM 30-Jun-2024 | FY 2024 31-Mar-2024 | FY 2023 31-Mar-2023 | FY 2022 31-Mar-2022 |
---|---|---|---|---|
EV | 77,134 | 73,158 | 80,211 | 93,589 |
Revenue | 108,782 | 113,054 | 108,096 | 76,701 |
EBITDA | 18,032 | 19,276 | 14,646 | 14,548 |
Net Income | 1,092 | (214) | 1,221 | (2,879) |
Total Assets | 147,262 | 155,733 | 161,329 | 139,225 |
Total Debt | 46,835 | 49,896 | 70,083 | 54,862 |
Medexus Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Medexus Pharmaceuticals Comparisons
Industry
Financing
Details
Medexus Pharmaceuticals Competitors (65)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Bluefish Pharmaceuticals | Private Equity-Backed | Stockholm, Sweden | ||||
Regeneron Pharmaceuticals | Formerly VC-backed | Tarrytown, NY | ||||
Pfizer Pakistan | Corporation | Karachi, Pakistan | ||||
Novartis | Corporation | Basel, Switzerland | ||||
Takeda Pharmaceutical Company | Corporation | Tokyo, Japan |
Medexus Pharmaceuticals Signals
Medexus Pharmaceuticals Investments & Acquisitions (4)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Aptevo Therapeutics (IX therapeutic) | 28-Feb-2020 | Buildings and Property | |||
Medac Pharma | 16-Oct-2018 | Pharmaceuticals | |||
Relaxa | 19-Sep-2016 | Buildings and Property | |||
Chelsea Acquisition | 15-Jul-2013 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
Medexus Pharmaceuticals FAQs
-
When was Medexus Pharmaceuticals founded?
Medexus Pharmaceuticals was founded in 2003.
-
Where is Medexus Pharmaceuticals headquartered?
Medexus Pharmaceuticals is headquartered in Toronto, Canada.
-
What is the size of Medexus Pharmaceuticals?
Medexus Pharmaceuticals has 82 total employees.
-
What industry is Medexus Pharmaceuticals in?
Medexus Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Medexus Pharmaceuticals a private or public company?
Medexus Pharmaceuticals is a Public company.
-
What is Medexus Pharmaceuticals’s stock symbol?
The ticker symbol for Medexus Pharmaceuticals is MDP.
-
What is the current stock price of Medexus Pharmaceuticals?
As of 05-Nov-2024 the stock price of Medexus Pharmaceuticals is $1.65.
-
What is the current market cap of Medexus Pharmaceuticals?
The current market capitalization of Medexus Pharmaceuticals is $40.4M.
-
What is Medexus Pharmaceuticals’s current revenue?
The trailing twelve month revenue for Medexus Pharmaceuticals is $109M.
-
Who are Medexus Pharmaceuticals’s competitors?
Bluefish Pharmaceuticals, Regeneron Pharmaceuticals, Pfizer Pakistan, Novartis, and Takeda Pharmaceutical Company are some of the 65 competitors of Medexus Pharmaceuticals.
-
What is Medexus Pharmaceuticals’s annual earnings per share (EPS)?
Medexus Pharmaceuticals’s EPS for 12 months was $0.05.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »